<DOC>
	<DOCNO>NCT00398294</DOCNO>
	<brief_summary>To collect lipid-lowering response data use simvastatin 40 mg tablet patient hypercholesterolemia .</brief_summary>
	<brief_title>To Evaluate Lipid-Lowering Efficacy Safety Simvastatin 40 Mg Tablet In Patients With Hypercholesterolemia ( 0733-264 )</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>Male female patient , &gt; 18 year age Patients hypercholesterolemia meet follow lipid criterion : 1. primary cholesterolemia : total cholesterol &gt; =240 mg/dl ldlc &gt; = 160 mg/dl 2. secondary cholesterolemia ( patient cad , dm ) : ldlc &gt; =130 mg/dl The patient willing follow NCEP therapeutic lifestyle change ( tlc ) similar cholesterollowering diet throughout duration study Congestive heart failure ( NYHA class III IV ) , uncontrolled cardiac arrhythmia , unstable angina pectoris Myocardial infarction , coronary artery bypass surgery , angioplasty within 3 month visit 1 Uncontrolled hypertension systolic blood pressure &gt; 160 mmhg diastolic &gt; 100 mmhg visit 1 . Unstable diabetes ( hba1c &gt; 9 % ) newly diagnose ( within 3 month ) change antidiabetes medication within 3 month screen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>